Video

Live from ASH: Dr. David Henry shares his 'did you know' picks


 

Dr. David Henry, the editor-in-chief of the Community Oncology journal, shares some of his "did you know" picks from the annual meeting of the American Society of Hematology. His 5-minute report reviews the new international prognostic scoring system for myelodysplastic syndromes, gene expression profiling for diffuse large b-cell lymphoma, approach to Waldenstrom's macroglobulin anemia, gray zone lymphoma, multiple myeloma updates, and more.

Recommended Reading

Experimental Ibrutinib Could Change Treatment of CLL
MDedge Hematology and Oncology
Induction Anthracycline Skipped in Pediatric Leukemia Regimen
MDedge Hematology and Oncology
With Ponatinib, CML Resistance Is Squashed - For Now
MDedge Hematology and Oncology
Fewer Deaths with Tighter Hematocrit Target in Polycythemia Vera
MDedge Hematology and Oncology
HEM-ONC CHAT: Dr. Elias Jabbour, 'Treatment a la Carte in CML'
MDedge Hematology and Oncology
Experimental quizartinib gives bridge to transplant in relapsed AML
MDedge Hematology and Oncology
Targeting new myeloma pathway pays off with ARRY-520
MDedge Hematology and Oncology
FDA approves ponatinib for CML and Ph-positive ALL
MDedge Hematology and Oncology
Chemo-free combo tames 'worst of the worst' acute leukemia
MDedge Hematology and Oncology
TOPPS: Limit prophylactic platelets to select groups
MDedge Hematology and Oncology